CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the ...

Shares in major healthcare companies that own pharmacy benefit manager businesses took a nosedive after comments from president-elect Trump.

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price ...

A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say ...

The Justice Department unsealed a civil complaint Wednesday alleging CVS Pharmacy Inc. and various subsidiaries filled “unlawful” prescriptions ... he would be raising prices for Americans.

including two antitrust cases accusing CVS Caremark Corp. and other pharmacy benefit managers, the intermediaries between insurance companies and pharmacies, of price-fixing prescription drug ...

The U.S. Department of Justice filed a civil complaint against CVS Pharmacy ... for each unlawful prescription and additional damages for federally reimbursed prescriptions. Price Action: CVS ...

CVS Health's Medicaid business ... aware of how big pharma profits from high drug prices, but few understand the market distortions introduced by pharmacy benefit management (PBM) companies ...

It’s become common for one company to own both a PBM and a pharmacy. CVS, Cigna and UnitedHealth ... “They negotiate with drug manufacturers and negotiate prices with pharmacies,” said ...

An analysis by natey1015 on ValueInvestorsClub offers a bearish perspective for CVS Health, a stock that has fallen by almost ...